Drugs / ABOR2014
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05981066 | Jul 2023 → Dec 2024 | hepatocellular carcinoma | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABOR2014 | “Patients will receive a fixed applicable dose of ABOR2014(IPM511) administered.” NCT05981066 ↗ |
| Known as | IPM511 | “Patients will receive a fixed applicable dose of ABOR2014(IPM511) administered.” NCT05981066 ↗ |